{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:32:07Z","timestamp":1779301927956,"version":"3.51.4"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbrc.2025.152053","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:36:38Z","timestamp":1747740998000},"page":"152053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Characterization and comparison of two NPC cell lines, C17 and C666-1, as models for studying the pathogenesis of nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"772","author":[{"given":"Anna","family":"Makowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0627-9228","authenticated-orcid":false,"given":"Eva Miriam","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"G\u00f6schel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8879-4754","authenticated-orcid":false,"given":"Chao-Chung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Nothbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emel Aylin","family":"Toktamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali T.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0931","authenticated-orcid":false,"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Kontny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbrc.2025.152053_bib1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/1055-9965.EPI-20-1702","article-title":"The evolving epidemiology of nasopharyngeal carcinoma","volume":"30","author":"Chang","year":"2021","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152053_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10555-024-10176-9","article-title":"Epidemiology of nasopharyngeal carcinoma: current insights and future outlook","volume":"43","author":"Su","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbrc.2025.152053_bib3","doi-asserted-by":"crossref","DOI":"10.2196\/49968","article-title":"Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-Based global epidemiological profiling","volume":"9","author":"Zhang","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.bbrc.2025.152053_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2024.106891","article-title":"Global burdens of nasopharyngeal carcinoma in children and young adults and predictions to 2040","volume":"155","author":"Lei","year":"2024","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbrc.2025.152053_bib5","first-page":"37","article-title":"Emerging treatment options for nasopharyngeal carcinoma","volume":"7","author":"Zhang","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"issue":"11","key":"10.1016\/j.bbrc.2025.152053_bib6","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.31557\/APJCP.2019.20.11.3505","article-title":"Nasopharyngeal carcinoma (NPC) risk factors: a systematic review and meta-analysis of the association with lifestyle, diets, socioeconomic and sociodemographic in Asian region","volume":"20","author":"Okekpa","year":"2019","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40880-016-0174-3","article-title":"Associations of lifestyle and diet with the risk of nasopharyngeal carcinoma in Singapore: a case-control study","volume":"36","author":"Yong","year":"2017","journal-title":"Chin. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152053_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2012.01.007","article-title":"Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000\u20132011","volume":"22","author":"Hildesheim","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2025.152053_bib9","first-page":"297","article-title":"Current and emerging treatment options for nasopharyngeal carcinoma","volume":"5","author":"Spratt","year":"2012","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2025.152053_bib10","article-title":"Chemoradiotherapy plus immunotherapy for locoregionally advanced nasopharyngeal carcinoma: a cost-effectiveness analysis","author":"Liu","year":"2024","journal-title":"Head Neck"},{"key":"10.1016\/j.bbrc.2025.152053_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103244","article-title":"Induction chemotherapy plus concomitant chemoradiotherapy in nasopharyngeal carcinoma: an updated network meta-analysis","volume":"160","author":"Bongiovanni","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2025.152053_bib12","first-page":"157","article-title":"A novel immune evasion mechanism of LMP-1, an EBV-Primary oncogene, in nasopharyngeal carcinoma","volume":"72","author":"Yoshizaki","year":"2011","journal-title":"Adv. Otorhinolaryngol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F","article-title":"Nasopharyngeal carcinoma cell line (C666\u20131) consistently harbouring epstein-barr virus","volume":"83","author":"Cheung","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.152053_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1116143","article-title":"The role of epstein-barr virus in nasopharyngeal carcinoma","volume":"14","author":"Su","year":"2023","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.semdp.2015.02.021","article-title":"Nasopharyngeal carcinoma: a review","volume":"32","author":"Petersson","year":"2015","journal-title":"Semin. Diagn. Pathol."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152053_bib16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ijrobp.2006.05.064","article-title":"Relationship between pretreatment level of plasma epstein-barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma","volume":"66","author":"Ma","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv291","article-title":"Establishment and validation of prognostic nomograms for endemic nasopharyngeal carci-noma","volume":"108","author":"Tang","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.bbrc.2025.152053_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.24721","article-title":"Assessment of survival model performance following inclusion of epstein-barr virus DNA status in conventional TNM staging groups in epstein-barr virus-related nasopharyngeal carcinoma","volume":"4","author":"Li","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"16","key":"10.1016\/j.bbrc.2025.152053_bib19","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases","volume":"127","author":"Kanakry","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152053_bib20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12185-023-03660-5","article-title":"Committee for guidelines for the management of chronic active EBV disease, related disorders (the MHLW research team in Japan). Updated guidelines for chronic active epstein-barr virus disease","volume":"118","author":"Kawada","year":"2023","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bbrc.2025.152053_bib21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fonc.2020.00600","article-title":"Targeting epstein-barr virus in nasopharyngeal carcinoma","volume":"10","author":"Hau","year":"2020","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152053_bib23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41374-018-0034-7","article-title":"Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic epstein-barr virus reactivation","volume":"98","author":"Yip","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2025.152053_bib24","doi-asserted-by":"crossref","unstructured":"Makowska A, Kontny U, van Helden J, Hildebrandt B, Sch\u00fcler HM, Weiskirchen R. Genetic characterization of the immortalized human nasopharyngeal carcinoma cell line NPC\/HK1. Cancer Med., doi: 10.1002\/cam4.70422. ePub ahead of print.","DOI":"10.1002\/cam4.70422"},{"issue":"18","key":"10.1016\/j.bbrc.2025.152053_bib25","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1128\/JVI.01457-14","article-title":"Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes","volume":"88","author":"Strong","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.152053_bib26","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ijc.23374","article-title":"Authentication of nasopharyngeal carcinoma tumor lines","volume":"122","author":"Chan","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.152053_bib27","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1096\/fj.14-266718","article-title":"Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China","volume":"29","author":"Ye","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2025.152053_bib28","series-title":"Assay Guidance Manual [Internet]","article-title":"Authentication of human and mouse cell lines by short tandem repeat (STR) DNA genotype analysis. 2023 Jan 17","author":"Almeida","year":"2004"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152053_bib29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152053_bib30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nbt.3820","article-title":"Nextflow enables reproducible computational workflows","volume":"35","author":"Di Tommaso","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.bbrc.2025.152053_bib31","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1158\/1078-0432.CCR-09-3178","article-title":"The tumor suppressor UCHL1 forms a complex with p53\/MDM2\/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma","volume":"16","author":"Li","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152053_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044228","article-title":"Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells","volume":"7","author":"Meganathan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.152053_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.104068","article-title":"Bottom up proteomics identifies neuronal differentiation pathway networks activated by cathepsin inhibition treatment in neuroblastoma cells that are enhanced by concurrent 13-cis retinoic acid treatment","volume":"232","author":"Halakos","year":"2021","journal-title":"J Proteomics"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib34","first-page":"396","article-title":"Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding","volume":"12","author":"Castillo","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152053_bib35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/2767-9764.CRC-23-0341","article-title":"Establishment and characterization of an epstein-barr virus-positive cell line from a non-keratinizing differentiated primary nasopharyngeal carcinoma","volume":"4","author":"Chai","year":"2024","journal-title":"Cancer Res. Commun."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152053_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/09273948.2014.968265","article-title":"Genotypic detection of epstein barr virus from clinically suspected viral retinitis patients in a tertiary eye care centre, India","volume":"23","author":"Janani","year":"2015","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00001-20","article-title":"mSphere of influence: expanding the CRISPR sphere with single-locus proteomics","volume":"5","author":"Glover","year":"2020","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-2249.2000.01105.x","article-title":"Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis","volume":"119","author":"Melichar","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152053_bib39","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1167\/iovs.07-1606","article-title":"PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro","volume":"49","author":"Yang","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152053_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137646","article-title":"PD-1, PD-L1 and PD-L2 gene expression on T-cells and natural killer cells declines in conjunction with a reduction in PD-1 protein during the intensive phase of tuberculosis treatment","volume":"10","author":"Hassan","year":"2015","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.bbrc.2025.152053_bib41","doi-asserted-by":"crossref","first-page":"9277","DOI":"10.1074\/jbc.RA117.001507","article-title":"Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1","volume":"293","author":"Dery","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152053_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41389-020-00248-0","article-title":"Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncogenesis"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152053_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125544","article-title":"Human induced pluripotent stem cells are targets for allogeneic and autologous natural killer (NK) cells and killing is partly mediated by the activating NK receptor DNAM-1","volume":"10","author":"Kruse","year":"2015","journal-title":"PLoS One"},{"issue":"41","key":"10.1016\/j.bbrc.2025.152053_bib44","doi-asserted-by":"crossref","first-page":"67360","DOI":"10.18632\/oncotarget.11744","article-title":"HLA-E expression and its clinical relevance in human renal cell carcinoma","volume":"7","author":"Seliger","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152053_bib45","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/2211-5463.12854","article-title":"Interferon-\u03b3-induced HLA class II expression on endothelial cells is decreased by inhibition of mTOR and HMG-CoA reductase","volume":"10","author":"Maenaka","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"11","key":"10.1016\/j.bbrc.2025.152053_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003134","article-title":"TIGIT\/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment","volume":"9","author":"Kawashima","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3892\/or.2012.2070","article-title":"Expression and clinical significance of HMGB1 in human liver cancer: knockdown inhibits tumor growth and metastasis in vitro and in vivo","volume":"29","author":"Dong","year":"2013","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152053_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7171\/jbt.18-2902-002","article-title":"The cellosaurus, a cell-line knowledge resource","volume":"29","author":"Bairoch","year":"2018","journal-title":"J. Biomol. Tech."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152053_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218412","article-title":"Interlaboratory study to validate a STR profiling method for intraspecies identification of mouse cell lines","volume":"14","author":"Almeida","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbrc.2025.152053_bib51","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ijc.23374","article-title":"Authentication of nasopharyngeal carcinoma tumor lines","volume":"122","author":"Chan","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.bbrc.2025.152053_bib52","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1096\/fj.14-266718","article-title":"Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China","volume":"29","author":"Ye","year":"2015","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib53","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-018-06889-5","article-title":"Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-Positive nasopharyngeal carcinoma","volume":"9","author":"Lin","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152053_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/cco.2016.03.06","article-title":"Genetic and epigenetic landscape of nasopharyngeal carcinoma","volume":"5","author":"Dai","year":"2016","journal-title":"Chin. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.bbrc.2025.152053_bib55","doi-asserted-by":"crossref","first-page":"22176","DOI":"10.18632\/aging.203521","article-title":"Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-Sequencing and bioinformatic analysis","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib56","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41467-021-21795-z","article-title":"Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma","volume":"12","author":"Gong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.152053_bib57","first-page":"457","article-title":"Oncogene mutational profile in nasopharyngeal carcinoma","volume":"7","author":"Zhang","year":"2014","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib58","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1186\/s12885-020-07408-w","article-title":"Upregulation of long non-coding RNA LOC284454 May serve as a new serum diagnostic biomarker for head and neck cancers","volume":"20","author":"Fan","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2025.152053_bib59","series-title":"Human Herpesviruses","article-title":"Encyclopedia of EBV-Encoded lytic genes: an update","volume":"vol.1045","author":"Murata","year":"2018"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/JCI182768","article-title":"Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma","volume":"135","author":"Zeng","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13046-018-0953-6","article-title":"EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-\u03baB and Erk1\/2 pathways","volume":"37","author":"Lin","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152053_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1297994","article-title":"Epstein-barr virus: the mastermind of immune chaos","volume":"15","author":"Silva","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152053_bib63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.4448","article-title":"The role of epstein-barr virus in epithelial malignancies","volume":"235","author":"Tsao","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbrc.2025.152053_bib64","series-title":"Pathogens Associated with the Development of Cancer in Humans","article-title":"Epstein-barr virus: a novel dimension in cancer development","author":"Molina-Herrera","year":"2024"},{"key":"10.1016\/j.bbrc.2025.152053_bib65","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fonc.2018.00265","article-title":"Epstein-barr virus-associated malignancies: roles of viral oncoproteins in carcinogenesis","volume":"8","author":"El-Sharkawy","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11684-016-0436-0","article-title":"Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing","volume":"10","author":"Hu","year":"2016","journal-title":"Front. Med."},{"issue":"23","key":"10.1016\/j.bbrc.2025.152053_bib67","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.3390\/cancers14235780","article-title":"Functional implications of epstein-barr virus lytic genes in carcinogenesis","volume":"14","author":"Yap","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.bbrc.2025.152053_bib68","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-9378-8-29","article-title":"Complete genomic sequence of epstein-barr virus in nasopharyngeal carcinoma cell line C666-1","volume":"8","author":"Tso","year":"2013","journal-title":"Infect Agent Cancer"},{"issue":"11","key":"10.1016\/j.bbrc.2025.152053_bib70","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3390\/microorganisms8111824","article-title":"Epstein-barr virus: how its lytic phase contributes to oncogenesis","volume":"8","author":"Rosemarie","year":"2020","journal-title":"Microorganisms"},{"issue":"9","key":"10.1016\/j.bbrc.2025.152053_bib71","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/cancers13092275","article-title":"Roles of lytic viral replication and co-infections in the oncogenesis and immune control of the epstein-barr virus","volume":"13","author":"Deng","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.bbrc.2025.152053_bib72","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.3390\/cancers15072120","article-title":"Contribution of epstein-barr virus lytic proteins to cancer hallmarks and implications from other oncoviruses","volume":"15","author":"Dorothea","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011934","article-title":"EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation","volume":"20","author":"Xu","year":"2024","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib74","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1186\/s12885-024-12564-4","article-title":"Early change of plasma epstein-barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy","volume":"24","author":"Lin","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2025.152053_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-025-03341-z","article-title":"Characterizing resistant cellular states in nasopharyngeal carcinoma during EBV lytic induction","author":"Wang","year":"2025","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152053_bib76","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/cancers16050991","article-title":"Epigenetic mechanisms in latent epstein-barr virus infection and associated cancers","volume":"16","author":"Torne","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2025.152053_bib77","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1038\/s41467-024-48333-x","article-title":"The nucleic acid binding protein SFPQ represses EBV lytic reactivation by promoting histone H1 expression","volume":"15","author":"Murray-Nerger","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.152053_bib78","first-page":"181","article-title":"EBV noncoding RNAs","volume":"391","author":"Skalsky","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152053_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00219-23","article-title":"Epstein-barr virus LMP1 enhances levels of large ex-tracellular vesicle-associated PD-L1","volume":"97","author":"Abou Harb","year":"2023","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.bbrc.2025.152053_bib80","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-20-4321","article-title":"Epstein-barr virus-encoded circular RNA circBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1","volume":"81","author":"Ge","year":"2021","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152053_bib81","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbamem.2013.04.018","article-title":"EpCAM: structure and function in health and disease","volume":"1828","author":"Schnell","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"15","key":"10.1016\/j.bbrc.2025.152053_bib82","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1073\/pnas.91.15.7202","article-title":"Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene","volume":"91","author":"D'souza","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152053_bib83","first-page":"4726","article-title":"Expression of epidermal growth factor receptor in human cultured cells and tissues: re-lationship to cell lineage and stage of differentiation","volume":"46","author":"Real","year":"1986","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152053_bib84","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","article-title":"ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152053_bib85","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-20-2584","article-title":"B7-H3: an attractive target for antibody-based immunotherapy","volume":"27","author":"Kontos","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152053_bib86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41419-017-0013-8","article-title":"Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN\/AKT\/mTOR pathway","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152053_bib87","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/biomedicines12051129","article-title":"Regulation of the function and expression of EpCAM","volume":"12","author":"Xiao","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2025.152053_bib88","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40164-022-00352-4","article-title":"Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside","volume":"11","author":"Liu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2025.152053_bib89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-5956-9-35","article-title":"Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics","volume":"9","author":"Ruan","year":"2011","journal-title":"Proteome Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152053_bib90","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/sj.bjc.6690057","article-title":"Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer","volume":"79","author":"Liu","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbrc.2025.152053_bib91","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1158\/2326-6066.CIR-22-0374","article-title":"EBV-Upregulated B7-H3 inhibits NK cell-mediated antitumor function and contributes to nasopharyngeal carcinoma progression","volume":"11","author":"Chen","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152053_bib92","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-4608(01)00542-8","article-title":"Absence of evidence for HER2 amplification in nasopharyngeal carcinoma","volume":"132","author":"Yan","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152053_bib93","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.7150\/jca.12825","article-title":"High expression of FGFR4 enhances tumor growth and metastasis in nasopharyngeal carcinoma","volume":"6","author":"Shi","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbrc.2025.152053_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.932353","article-title":"RET signaling pathway and RET inhibitors in human cancer","volume":"12","author":"Regua","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152053_bib95","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10637-010-9451-1","article-title":"Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma","volume":"29","author":"Hui","year":"2011","journal-title":"Invest New Drugs"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152053_bib96","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7150\/jca.49392","article-title":"Identifying key genes for nasopharyngeal carcinoma by prioritized consensus differentially expressed genes caused by aberrant methylation","volume":"12","author":"Chen","year":"2021","journal-title":"J. Cancer"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T13:12:31Z","timestamp":1752844351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25007673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":94,"alternative-id":["S0006291X25007673"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152053","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization and comparison of two NPC cell lines, C17 and C666-1, as models for studying the pathogenesis of nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152053"}}